Jun Zhang

Medical Oncologist

[ASCO @ASCO]

2nd Plenary #ASCO25: #NIVOPOSTOP Ph III, adj Nivolumab w/ ChemoXRT in high risk squamous cell head & neck ca after surgery.

- 3yr DFS: 63.1% vs 52.5% (HR: 0.76). Benefit in all subgroups including CPS/PDL1
- Similar AEs in both arms
- Is benefit driven by locations control?

[Jun Zhang @Junzhang007]

#ASCO2023 @EthanBurns_MD What a wonderful conclusion of the hematology oncology fellowship training @HMethodistGME Congratulations on starting a new chapter in your career! @HMethodistMD @MethodistHosp

[Jun Zhang @Junzhang007]

@EthanBurns_MD @HMinternalmed @EjazJanjua7 @MelinaAwar @MaenAbdelrahim @JennyCChang1 Well done！So proud of you guys!

[Jenny C. Chang @JennyCChang1]

Congrats #RyanKieser @asco22 so proud of you #hmhcancercenter ⁦@HMethodistMD⁩ ⁦@HMethodistGME⁩

[Jenny C. Chang @JennyCChang1]

⁦Way to go Dr Kai Sun for the prestigious ASCO YIA for #tnbc #HMethodistMD ⁦@HMinternalmed⁩ #hmcancercenter ⁦@BCSMChat⁩

[Jun Zhang @Junzhang007]

@EthanBurns_MD @AkshjotP @HMethodistMD @HMethodistGME Perfect witness to tell how good we treat our fellows😂

[Jun Zhang @Junzhang007]

Very excited to have our new fellows joining us ! #hematology #oncology #fellowship. Welcome aboard, Zimu and Jian! @HMethodistMD @HMethodistGME

[Jun Zhang @Junzhang007]

@JennyCChang1 @HMethodistMD @HMH_IMres Well deserved! Congratulations, Polly!